Our July 22, 2021 webinar featured Toshio Yamaguchi, M.D., Ph.D. from Shin-yurigaoka General Hospital
presenting:
"Focused Ultrasound in the Brain: Clinical Applications and Technical Challenges in Japan"
Dr. Yamaguchi is Director of Research Institute for Diagnostic Radiology at Shin-yurigaoka General Hospital. He has taken up his current position in 2012 as Director of Research institute of Diagnostic Radiology at Shin-yurigaoka General Hospital. Dr. Yamaguchi has involved in clinical focused ultrasound brain therapy since 2013, when ExAblate was first installed at his hospital in Japan. His clinical work and research are concentrated on refinement of neuro-focused ultrasound to clinical use, focusing on how accurately and safely FUS can treat the patients in the brain, using advanced medical imaging. He has been involved in the clinical studies, Parkinsons disease (PTT and GPi), focal hand dystonia and epilepsy for the last 5 years. He will present the clinical applications and technical challenges in Japan from his 8-year clinical experiences.
This session was moderated by Pejman Ghanouni, M.D., Ph.D., Associate Professor of Radiology at Stanford University. His research and clinical work are concentrated on translation of focused ultrasound to clinical use. He uses MR guided focused ultrasound to treat patients with essential or Parkinson’s tremor, bone and soft tissue tumors, uterine fibroids, and prostate cancer, having participated in clinical trials of MRgFUS for each of these indications. He currently co-leads trials applying MR guided focused ultrasound to the treatment of pancreatic cancer and epilepsy. Dr. Ghanouni directs Stanford’s Minimally Invasive MR Interventional Center and co-directs the Stanford Focused Ultrasound Foundation Center of Excellence.
We want to extend our gratitude to our Industry Partner for their support of this webinar.
Please visit their online exhibit booth to learn more about their products.
